On Dec. 12, Vertiv Holdings Co. NYSE: VRT closed nearly 10% lower at $161.14—a sharp correction that startled investors. However, the decline was not driven by a deterioration in Vertiv's business fundamentals, but rather by market reactions to external factors—most notably, Oracle's NYSE: ORCL most recent earnings report and an analyst downgrade from Wolfe Research.

The FT Energy Income Partners Enhanced Income ETF is rated Buy for its defensive, cash flow-driven portfolio and sustainable yield structure. EIPI employs partial covered call writing (25-75% coverage), balancing income generation with upside capture in volatile energy markets. The ETF's underlying holdings yield ~4.5-5%, supporting an 8.65% TTM yield with minimal reliance on option premiums.

SpaceX's anticipated IPO presents an interesting idea to gain exposure to the rapidly expanding commercial space sector. Compared to the publicly traded Rocket Lab Corporation, my estimate show SpaceX to be a package combining growth, value, and market positioning. Starlink's vertical integration can potentially transform SPACE into a global telecom provider.

Nike Inc (NYSE) will be one of the last companies to step into the earnings confessional for 2025, when the athletic retailer fiscal second-quarter earnings after the close on Thursday, Dec. 18.

New York, New York--(Newsfile Corp. - December 15, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Stride, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/stride-inc-class-action-lawsuit.

New York, New York--(Newsfile Corp. - December 15, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Integer Holdings Corporation (NYSE: ITGR) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Integer, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/integer-holdings-corporation-class-action-lawsuit.

New York, New York--(Newsfile Corp. - December 15, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against James Hardie Industries plc (NYSE: JHX) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in James Hardie, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/james-hardie-industries-class-action-lawsuit.

New York, New York--(Newsfile Corp. - December 15, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Inspire, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/inspire-medical-systems-inc-class-action-lawsuit.

New York, New York--(Newsfile Corp. - December 15, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Freeport-McMoRan Inc. (NYSE: FCX) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Freeport, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/freeport-mcmoran-inc-class-action-lawsuit.

New York, New York--(Newsfile Corp. - December 15, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. (NYSE: ARE) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Alexandria Real Estate, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/alexandria-real-estate-class-action-lawsuit.

New York, New York--(Newsfile Corp. - December 15, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CarMax, Inc. (NYSE: KMX) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in CarMax, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/carmax-inc-class-action-lawsuit.

New York, New York--(Newsfile Corp. - December 15, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Synopsys, Inc. (NASDAQ: SNPS) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Synopsys, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/synopsys-inc-class-action-lawsuit.

Copart, Inc. receives a Buy rating, supported by a strong moat, capital-light model, and a rock-solid, debt-free balance sheet with $5.2 billion in cash. Despite recent revenue and unit volume declines, CPRT's network effects, strategic land ownership, and financial flexibility underpin long-term competitive advantages. Short-term risks include market share loss to RB Global, Inc. (RBA) and weak quarterly figures, but historical outperformance and attractive valuation offer compelling entry points.

NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Gauzy Ltd. (NASDAQ: GAUZ) between March 11, 2025 and November 13, 2025. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 6, 2026 .

Billings Clinic-Logan Health, Children's Hospital Los Angeles, and Regency Integrated Health Services move business applications to the cloud AUSTIN, Texas , Dec. 15, 2025 /PRNewswire/ -- Leading healthcare organizations are implementing Oracle Fusion Cloud Applications to help increase productivity, reduce costs, and enhance the experience they deliver to employees and patients. Billings Clinic-Logan Health, Children's Hospital Los Angeles, and Regency Integrated Health Services are leveraging Oracle Fusion Applications to streamline finance, HR, supply chain, and customer experience processes in the cloud.

Columbia Threadneedle Investments just released six new ETFs, including five which are actively managed and one tied to an index. All funds target specific segments in the equities as well as the fixed income market.

BOSTON, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced that its Chief Executive Officer, Ivor Elrifi, has purchased 163,400 shares of Tiziana common stock in the open market. This brings his current purchased shares total to 357,848.

BETA Technologies aims to revolutionize aerospace with electric aircraft, but faces significant near-term losses and delayed commercial certification. Despite a $3.5 billion backlog and 891 aircraft orders, only 289 are firm, and average plane prices appear high relative to current capabilities. BETA's Q3 revenue was $8.9 million with a $67 million negative EBITDA, and Q4 losses are expected to worsen, pressuring its $1.8 billion cash position.

SAN DIEGO--(BUSINESS WIRE)---- $TLX #Telix--Robbins LLP: Company: Telix Pharmaceuticals Ltd. (NASDAQ: TLX) is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. What is the class period? February 21, 2025 - August 28, 2025 What is the case about? Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or acquired Telix securities during the class peri.

Shares of Broadcom, CoreWeave and Oracle all dropped on Monday, extending last week's declines. While the artificial intelligence boom shows no signs of easing, investors have grown concerned about how it will all be financed.